ARTICLE | Clinical News
Infuse bone graft/LT-cage lumbar tapered fusion device regulatory update
April 14, 2003 7:00 AM UTC
Canada granted marketing approval for Infuse used with LT-cage to treat certain types of spinal degenerative disk disease. Infuse contains recombinant human bone morphogenic protein (rhBMP-2), which i...